Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Yearly Sales Target At $2.505


The EPS projection of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for quarter ended 2016-09-30 is $-1.57. A week before, the EPS forecast was $-1.57 against target of $-1.57, a month earlier. This estimate stood at $-1.57 60 days earlier versus forecast of $-1.57 90 days earlier, confirming a deviation of 0%.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 1.

In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 1, 0 and 1, respectively.

The downgrade of EPS estimates for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in the preceding 120, 60, 30 and 90 days were 2, 4, 0 and 4, in that order.

Earnings Surprises

As per the latest update, for the quarter closed 1, the EPS estimate of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) was $-1.57. This projection was computed after accounting 9 calls. As reported on 2016-05-09 the EPS was $-1.35. The change was $-0.06, demonstrating a percentage deviation of -4.65%. The projections confirmed a standard deviation of 0.15.

Quarterly Sales Estimates

For the fiscal 2016, the yearly sales target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stands at $2.505 and the median estimate at $2.505. Almost 2 analysts announced their estimates.

The highest estimate is $4.49 while the lowest target is $0.52 showing standard deviation of 2.807%.

As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.

In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.

A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stated that the change in forecast was 0%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 7 times, 1 visits today)